glp 1 weight loss study Virta Health announces first-of-its-kind peer-reviewed proving its approach is an effective off-ramp from GLP-1s for sustained Rx Trends: Real-World Data on

R., Moore, D

MATERIAL AND METHODS: A longitudinal study, case series in 25 participants, both sexes, aged 3-16 years old, with chronic renal failure and hemodialysis was performed

This was about a decade ago

The multifaceted benefits from GLP-1RAs extend beyond glycemic control to include substantial improvements in cardiovascular and renal health, positioning these agents as a cornerstone of modern diabetes management

No they're complementary rather than substitutable

In a previous cohort study comparing GLP-1RAs with anti-obesity medications bupropion-naltrexone in patients with obesity who had no T2DM [45] showed an increased risk of bowel obstruction